Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the resilient randomized trial

Journal of Endovascular Therapy

Volumn 19, Issue 1, 2012, Pages 1-9

  Laird, John R ^a   Katzen, Barry T ^d   Scheinert, Dierk ^e   Lammer, Johannes ^f   Carpenter, Jeffrey ^g   Buchbinder, Maurice ^b   Dave, Rajesh ^h   Ansel, Gary ⁱ   Lansky, Alexandra ^j   Cristea, Ecaterina ^k   Collins, Tyrone J ^l   Goldstein, Jeffrey ^m   Cao, Annie Y ^c   Jaff, Michael R ⁿ  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SCRIPPS CLINIC   (United States)

^c EDWARDS LIFESCIENCES   (United States)

^d Baptist Heart and Vascular Center   (United States)

^e UNIVERSITY OF LEIPZIG HEART CENTER   (Germany)

^f MEDICAL UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Pinnacle Health System   (United States)

ⁱ RIVERSIDE METHODIST HOSPITAL   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^l Oschner Clinic Foundation   (United States)

^m Prairie Education and Research Center   (United States)

ⁿ MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Balloon angioplasty; Claudication; Femoropopliteal segment; Outcome analysis; Peripheral vascular disease; Popliteal artery; Quality of life outcome; Stenosis; Stents; Superficial femoral artery

Indexed keywords

NITINOL;

ADULT; AGED; ARTICLE; CLAUDICATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL VASCULAR DISEASE; POPLITEAL ARTERY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; RISK FACTOR; SHORT FORM 8; STENOSIS; SUPERFICIAL FEMORAL ARTERY; SURVIVAL RATE; TREATMENT OUTCOME; VASCULAR PATENCY;

AGED; ALLOYS; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CHI-SQUARE DISTRIBUTION; CONSTRICTION, PATHOLOGIC; EUROPE; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; POPLITEAL ARTERY; PREDICTIVE VALUE OF TESTS; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; UNITED STATES; VASCULAR PATENCY;

EID: 84857133568     PISSN: 15266028     EISSN: 15451550     Source Type: Journal    
DOI: 10.1583/11-3627.1     Document Type: Article

References (26)

1. Mwipatayi BP, Hockings A, Hofmann M, et al. Balloon angioplasty compared with stenting for treatment of femoropopliteal occlusive disease: a meta-analysis. J Vasc Surg. 2008; 47:461-469. (Pubitemid 351172652)
2. Kasapis C, Henke PK, Chetcuti SJ, et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J. 2009;30:44-55.
3. Dearing DD, Patel KR, Compoginis JM, et al. Primary stenting of the superficial femoral and popliteal artery. J Vasc Surg. 2009;50:542-548.
4. Schillinger M, Sabeti S, Loewe C, et al. Balloon Angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354:1879-1888. (Pubitemid 43872689)
5. Laird JR, Katzen BT, Scheinert D, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the resilient randomized trial. Circ Cardiovasc Interv. 2010;3:267-276.
6. Dick P, Wallner H, Sabeti S, et al. Balloon angioplasty versus stenting with nitinol stents in intermediate length superficial femoral artery lesions. Catheter Cardiovasc Interv. 2009; 74:1090-1095.
7. Bosiers M, Torsello G, Gissler HM, et al. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-269.
8. Schillinger M, Sabeti S, Dick P, et al. Sustained benefit a 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;115:2745-2749. (Pubitemid 46842791)
9. Scheinert D, Scheinert S, Sax J, et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol. 2005;45:312-315. (Pubitemid 40094743)
10. Nikanorov A, Smouse HB, Osman K, et al. Fracture of self-expanding nitinol stents stressed in vitro under simulated intravascular conditions. J Vasc Surg. 2008;48:435-440.
11. Schlager O, Dick P, Sabeti S, et al. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther. 2005;12:676-684. (Pubitemid 43100925)
12. PopmaJJ,TirochK,AlmonacidA,etal.Aqualitative and quantitative angiographic analysis of stent fracture late following sirolimus eluting stent implantation.AmJ Cardiol. 2009;103:923-929.
13. Duda SH, Pusich B, Richter G, et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation. 2002;106:1505-1509.
14. Duda SH, Bosiers M, Lammer J, et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol. 2005;16:331-338. (Pubitemid 40354849)
15. Duda SH, Bosiers M, Lammer J, et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther. 2006;13:701-710. (Pubitemid 44907633)
16. Muller-Hü lsbeck S, Schafer PJ, Charalambous N, et al. Comparison of second-generation stents for application in the superficial femoral artery: an in vitro evaluation focusing on stent design. J Endovasc Ther. 2010;17:767-776.
17. Iida O, Nanto S, Uematsu M, et al. Effect of exercise on frequency of stent fracture in the superficial femoral artery. Am J Cardiol. 2006;98:272-274. (Pubitemid 43975509)
18. Gray BH, Sullivan TM, Childs MB, et al. High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg. 1997;25:74-83. (Pubitemid 27081611)
19. Saxon RR, Coffman JM, Gooding JM, et al. Long-term patency and clinical outcome of the Viabahn stent-graft for femoropopliteal artery obstructions. J Vasc Interv Radiol. 2007;18:1341-1350.
20. Farraj N, Srivastava A, Pershad A. One-year outcomes for recanalization of long superficial femoral artery chronic total occlusions with the Viabahn stent graft. J Invasive Cardiol. 2009;21:278-281.
21. McQuade K, Gable D, Hohman S, et al. Randomized comparison of ePTFE/nitinol self expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg. 2009;49:109-116.
22. Ferreira M, Lanziotti L, Monteiro M, et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg. 2007;34: 702-708. (Pubitemid 350056379)
23. Hu H, Zhang H, He Y, et al. Endovascular nitinol stenting for long occlusive disease of the superficial femoral artery in critical limb ischemia: a single-center, mid-term result. Ann Vasc Surg. 2011;25:210-216.
24. Ko YG, Kim JS, Choi DH, et al. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther. 2007;14:374-381.
25. Sabeti S, Czerwenka-Wenkstetten A, Dick P, et al. Quality of life after balloon angioplasty versus stent implantation in the superficial femoral artery: findings from a randomized controlled trial. J Endovasc Ther. 2007;14:431-437. (Pubitemid 350154987)
26. Dippel E, Shammas N, Takes V, et al. Twelve-month results of percutaneous endovascular reconstruction for chronically occluded superficial femoral arteries: a quality-of-life assessment. J Invasive Cardiol. 2006;18:316-321. (Pubitemid 44014130)